PropertyValue
is ?:annotates of
?:authorAffiliation
  • [\'Department of Internal Medicine, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran.\', \'Gastrointestinal and liver Diseases Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'School of Public Health, Isfahan University of Medical Sciences, Isfahan, Iran.\', \'Antimicrobial Resistance Research Center, Iran University of Medical Sciences, Tehran, Iran.\', \'Department of Infectious Diseases, Firoozgar Medical and Educational Hospital, Iran University of Medical Sciences, Tehran, Iran.\']
?:citedBy
  • -1
?:creator
?:doi
  • 10.34172/aim.2021.22
?:doi
?:hasPublicationType
?:journal
  • Archives of Iranian medicine
is ?:pmid of
?:pmid
?:pmid
  • 33636983
?:publication_isRelatedTo_Disease
?:rankingScore_SJR
  • 0.61
?:rankingScore_hIndex
  • 39
is ?:relation_isRelatedTo_publication of
?:title
  • Infliximab and Intravenous Gammaglobulin in Hospitalized Severe COVID-19 Patients in Intensive Care Unit.
?:type
?:year
  • 2021

Metadata

Anon_0  
expand all